Marina Abramov, Eden Goldfarb, Dikla Haham, Eyal Akiva, Jan-Willem van Klinken, Zohar Barbash
{"title":"A Nature-Derived Peptide Promotes Satiety Hormone Response and Weight Loss <i>In Vivo</i>.","authors":"Marina Abramov, Eden Goldfarb, Dikla Haham, Eyal Akiva, Jan-Willem van Klinken, Zohar Barbash","doi":"10.1080/19390211.2026.2752609","DOIUrl":"https://doi.org/10.1080/19390211.2026.2752609","url":null,"abstract":"<p><p>The global rise of obesity highlights the critical need for effective weight-management strategies. GLP-1 receptor agonists have transformed obesity care, yet gastrointestinal intolerance, high cost, and weight regain after discontinuation highlight the need for complementary, orally available options. An alternative is to stimulate the body's own GLP-1 release through the nutrient-sensing GPCRs on enteroendocrine L cells that a meal engages. Using an AI-guided screen of common food proteins, we identified nature-derived peptides (NDPs): sequences native to edible proteins that were reproduced synthetically and engage these receptors. Unlike peptide drugs engineered for systemic exposure, NDPs are intended to act locally at the gut epithelium. Our lead, NDP-35 (from <i>Coffea arabica</i>), is a potent, selective GPR40 agonist (EC<sub>50</sub> = 32.7 nM); in mice, it raised plasma GLP-1, GIP, and PYY while lowering hunger hormones, reproducing the coordinated satiety hormone response of a meal at minimal caloric cost. Over 28 days of oral dosing in diet-induced obese rats, NDP-35 reduced food intake and lowered body weight by ∼5%, versus a 3% gain in vehicle-treated animals; a subcutaneous semaglutide arm was included as a reference comparator and endpoint values were of similar magnitude to NDP-35. Terminal clinical chemistry and organ-weight markers showed no treatment-related changes over the dosing period. A structurally distinct peptide, NDP-45 (from banana), reproduced these effects. NDP-35 and NDP-45 are promising preclinical food-protein-derived peptide candidates that stimulate enteroendocrine hormone responses and reduce food intake and body weight in rodent models, warranting further evaluation as an oral approach to appetite and body-weight control.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"1-27"},"PeriodicalIF":3.1,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149342357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Multivitamins - A Scoping Review of Clinical Trials Examining Their Efficacy and Safety.","authors":"Zhongqi Fan, John M Nelson, Taylor C Wallace","doi":"10.1080/19390211.2025.2597204","DOIUrl":"https://doi.org/10.1080/19390211.2025.2597204","url":null,"abstract":"<p><p>Multivitamins are widely used, but variation in formulations, populations, and outcomes complicates assessment of their benefits and risks. This scoping review mapped clinical trial reports evaluating broad-spectrum multivitamins in adults. MEDLINE/PubMed, Cochrane Library, and Scopus were searched from inception through 9 September 2026. Independent dual screening and standardized data extraction followed Joanna Briggs Institute methodology, with reporting guided by PRISMA-ScR. Eligible supplements were capsules or tablets providing, per daily serving, ≥50% of U.S. National Academy of Medicine life-stage-specific Recommended Dietary Allowances or Adequate Intakes for ≥14 vitamins and minerals, including ≥2 vitamins and ≥2 minerals, without exceeding any applicable Tolerable Upper Intake Level. The review included 157 articles: 103 primary intervention reports and 54 interim, secondary, or post hoc reports. The most consistent findings were improvements in circulating folate and vitamins B6 and B12. Effects on other vitamin biomarkers varied by context and baseline nutritional status, whereas mineral biomarkers showed few consistent improvements, except for iodine, iron and zinc, which were context dependent. Potential clinical benefits emerged in selected prenatal and cognitive contexts, although findings varied across outcomes, populations, and comparators. Findings for cardiovascular disease prevention were largely null. Multivitamins were generally well tolerated across the populations studied, including pregnant women, older adults, and surgical patients. However, formulation-specific adverse effects, such as mild gastrointestinal symptoms with some formulations containing iron or zinc, and potential drug-nutrient interactions, such as vitamin K with warfarin, warrant attention. These findings support a nutritional role for broad-spectrum multivitamins without implying universal disease prevention. Priorities for focused systematic reviews and trials include linking related reports, characterizing baseline nutritional status, assessing clinically meaningful outcomes, and consistently reporting formulations and harms. The review was preregistered on Open Science Framework (https://osf.io/t476d).</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"1-48"},"PeriodicalIF":3.1,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149287085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Haijing Hu, Benjamin Redan, Mary Dawn Celiz, Rahul Pawar, Betsy Jean Yakes
{"title":"Perspective on Gummy Dietary Supplements Manufacturing and Testing.","authors":"Haijing Hu, Benjamin Redan, Mary Dawn Celiz, Rahul Pawar, Betsy Jean Yakes","doi":"10.1080/19390211.2026.2727022","DOIUrl":"https://doi.org/10.1080/19390211.2026.2727022","url":null,"abstract":"<p><p>The demand for dietary supplements in a gummy format has increased rapidly over the past several years. Consumers appear to be seeking a convenient, enjoyable, and palatable alternative to traditional dosage forms, such as tablets, capsules, and soft gels. However, gummy dietary supplements present various challenges in formulations, manufacturing, and analytical testing. This <i>Perspective</i> provides an overview of gummy formulation, highlights challenges related to manufacturing and testing and briefly identifies areas of novel formulations. Addressing these challenges is critical for product quality and safety, as well as improving product consistency, stability, and consumer confidence in gummy dietary supplements.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"1-12"},"PeriodicalIF":3.1,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148990229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Role of Probiotics in Parkinson's Disease - Current Evidence and Future Perspectives.","authors":"Elif Dadak Yıldırım, İlknur Gökçe Yıldırım","doi":"10.1080/19390211.2026.2729425","DOIUrl":"https://doi.org/10.1080/19390211.2026.2729425","url":null,"abstract":"<p><p>Parkinson's disease (PD) is a progressive neurodegenerative disorder with an increasing prevalence in the aging population. Current therapeutic approaches are largely symptomatic, and disease-modifying treatments capable of halting or slowing disease progression remain limited. This has led to growing interest in complementary and supportive strategies for the management of PD. In recent years, nutrition-related factors, particularly the gut microbiota, have attracted considerable attention due to their potential influence on the pathogenesis and clinical course of the disease. The microbiota-gut-brain axis, which describes the bidirectional communication between the gut microbiota and the central nervous system, is closely associated with key pathophysiological mechanisms of PD, including neuroinflammation, oxidative stress, and α-synuclein aggregation. Alterations in gut microbiota composition in individuals with PD have been reported to be associated with both motor and non-motor symptoms. In this context, microbiota-targeted interventions have emerged as a potential approach in disease management. Experimental and clinical studies suggest that probiotic supplementation may contribute to the improvement of gastrointestinal symptoms in patients with PD and may exert beneficial effects on certain neurological outcomes. However, evidence regarding the therapeutic efficacy of probiotics in PD remains limited, and further studies are required to clarify underlying mechanisms and strengthen clinical evidence. This narrative review aims to evaluate the therapeutic potential of probiotics in PD in light of current experimental and clinical evidence and to discuss possible mechanisms of action through the microbiota-gut-brain axis.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"1-20"},"PeriodicalIF":3.1,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148912169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julie Shlisky, Swati Kalgaonkar, Clayton S Bloszies, Jan-Willem van Kinken, Mario G Ferruzzi
{"title":"Bioavailability and Metabolism of N-Trans Caffeoyltyramine and N-Trans Feruloyltyramine - A Narrative Review.","authors":"Julie Shlisky, Swati Kalgaonkar, Clayton S Bloszies, Jan-Willem van Kinken, Mario G Ferruzzi","doi":"10.1080/19390211.2025.2597203","DOIUrl":"10.1080/19390211.2025.2597203","url":null,"abstract":"<p><p>Insights into the bioavailability of hemp derived phenolic amides N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) remained limited to experimental data from preclinical <i>in vitro</i> and animal systems. However, the bioavailability of similar phenolics and phenolic amides from other sources has been experimentally determined. This concise review summarizes the current state of knowledge for phenolic amides with the goal of providing experimental guidance on the assessment of NCT and NFT from hemp ingredients in humans. Evidence from phenolic and avenanthramide (similar phenolic amides from oats) suggest that overall absorption of free phenolic amides would be limited in humans to <2% of native forms. Metabolites derived by both host (conjugated Phase II metabolites) and microbial fermentation products would likely represent the main compounds in circulation derived from NCT or NFT intake. This would be extensively influenced by the matrix provided including hemp-based ingredients with large portions of physically and chemically bound NCT and NFT forms that are not absorbable. Experimental designs to determine NCT and NFT response in humans would need to consider longer exposure and collection periods to adequately capture 24 and 48h urine and blood samples likely to have key NCT and NFT derived microbial and host metabolites present. Considering adaptation of the microbiota to these compounds it is likely that a robust design would also include a dimension of long-term exposure to enable detection of target metabolites derived from hemp NCT and NFT.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"101-117"},"PeriodicalIF":2.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145714765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dimitrios Papandreou, Salwa Bader, Khaled Abass, Myriam Abboud, Sousana K Papadopoulou, Salah Abusnana
{"title":"Vitamin D Supplementation in Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials.","authors":"Dimitrios Papandreou, Salwa Bader, Khaled Abass, Myriam Abboud, Sousana K Papadopoulou, Salah Abusnana","doi":"10.1080/19390211.2026.2636469","DOIUrl":"10.1080/19390211.2026.2636469","url":null,"abstract":"<p><p>Vitamin D deficiency is prevalent in type 2 diabetes mellitus (T2DM) and may influence metabolic control. The efficacy of supplementation remains contested. This systematic review aimed to evaluate the effect of vitamin D supplementation on primary glycemic outcomes (HbA1c, fasting blood glucose [FBG], HOMA-IR) and secondary metabolic parameters (lipid profile, blood pressure, anthropometrics) in adults with T2DM or prediabetes. This review was conducted according to Cochrane methodology and reported following PRISMA 2020 guidelines. Randomized controlled trials (RCTs) were identified <i>via</i> systematic searches of PubMed, Scopus, and Web of Science up to March 2025. Study selection, data extraction, and risk of bias assessment (using Cochrane RoB 2 tool) were performed in duplicate. A narrative synthesis was performed due to substantial heterogeneity. Thirty RCTs (<i>n</i> = 2627) were included. Studies varied in vitamin D dosage (1,000 to 600,000 IU), duration (8-52 wk), and participant baseline status. Overall, supplementation consistently increased serum 25(OH)D levels. For primary outcomes, significant reductions in HbA1c and FBG were reported in approximately half of the studies, particularly among participants with baseline vitamin D deficiency. Effects on HOMA-IR were mixed. Secondary outcomes (lipids, blood pressure, BMI) showed minimal or inconsistent changes. Vitamin D supplementation may improve glycemic control in individuals with T2DM who are vitamin D deficient, but appears ineffective in those with sufficient levels. It does not consistently improve other metabolic parameters. Targeted supplementation based on individual vitamin D status is recommended, rather than universal administration.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"360-392"},"PeriodicalIF":2.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147389517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Darren G Candow, Jedd Pratt, Nicholas Fabiano, Ali Gordji-Nejad, Aaron Smith, Eric S Rawson, Terence Moriarty, Scott C Forbes, Chad M Kerksick
{"title":"Creatine Supplementation and the Brain: Have We Put the Cart Before the Horse?","authors":"Darren G Candow, Jedd Pratt, Nicholas Fabiano, Ali Gordji-Nejad, Aaron Smith, Eric S Rawson, Terence Moriarty, Scott C Forbes, Chad M Kerksick","doi":"10.1080/19390211.2026.2616440","DOIUrl":"10.1080/19390211.2026.2616440","url":null,"abstract":"<p><p>Creatine is an important regulator of brain bioenergetics, yet the efficacy of creatine supplementation (CrS) in the brain remains largely unknown. Measurement of brain creatine using proton (<sup>1</sup>H) and phosphorus (³<sup>1</sup>P) magnetic resonance spectroscopy is highly sensitive to voxel placement, signal quality, analysis pipelines, and reporting conventions which can obscure the detection of biological responses to CrS. There is evidence that CrS increases brain creatine, but this response may be dose and/or duration dependent. CrS provides some benefits during acute periods of metabolic stress such as sleep deprivation, mental fatigue, and hypoxia. Emerging clinical data also suggest potential therapeutic effects from CrS for Alzheimer's disease, major depressive disorder, and mild traumatic brain injury (mTBI), although findings across conditions remain preliminary and inconsistent. Further, CrS shows some promise for improving aspects of sleep quality. The purpose of this narrative review is to: (1) outline methodological considerations in the quantification of brain creatine, (2) discuss the divergent effects of CrS on brain creatine levels and measures of brain function, (3) examine the purported mechanistic actions of CrS for improving brain health and function, (4) highlight critical gaps and limitations which should be considered moving forward, and (5) identify future research directions involving CrS and the brain.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"175-204"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H N Siti, P L Lua, M N A Taib, M S Zulfarina, M L Nordin, M A Sharifudin
{"title":"Oral Curcumin for Tendon Health: An Appraisal on Carrier Systems, Bioenhancers, and Synergistic Formulations.","authors":"H N Siti, P L Lua, M N A Taib, M S Zulfarina, M L Nordin, M A Sharifudin","doi":"10.1080/19390211.2026.2662847","DOIUrl":"10.1080/19390211.2026.2662847","url":null,"abstract":"<p><p>Native curcumin's clinical utility is severely limited by poor solubility and rapid metabolism. While preclinical models demonstrate potent effects on tendon repair, achieving therapeutic concentrations in humans requires advanced formulation strategies. This review aims to reiterate the pharmacokinetic (PK) limitations inherent to native curcumin and critically appraise current oral formulation strategies designed to enhance its bioavailability. It further delineates the role of other adjunct compounds that may or may not be incorporated into curcumin formulations for tendon repair. By synthesizing available human pharmacokinetic data, this review evaluates the clinical potential of curcumin formulations in the management of tendinopathy. Human pharmacokinetic data on current curcumin delivery systems are synthesized. The primary functions of common formulation adjuncts such as piperine, EGCG, bromelain, and boswellia are evaluated for their benefits as bioenhancers or independent therapeutics for tendon health. Clinical outcomes from studies utilizing these combined formulations in tendinopathies are also reviewed. Analysis of dose-normalized PK data confirms that modern formulations significantly improve relative bioavailability compared to native curcumin. However, current evidence suggests that formulation adjuncts contribute primarily through independent biological pathways rather than direct PK bio-enhancement. Clinical evidence suggests these 'multimodal' formulations are associated with accelerated pain reduction, improved functional scores, and reduced non-steroidal antiinflammatory drugs consumption. Tendinopathy management is increasingly moving toward high-efficiency curcumin delivery paired with synergistic co-factors. While enhanced oral formulations show significant clinical association with improved recovery, future research should bridge the gap between plasma levels and direct intratendinous penetration.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"393-414"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147773036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adrian L Lopresti, Stephen J Smith, Peter D Drummond
{"title":"Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials.","authors":"Adrian L Lopresti, Stephen J Smith, Peter D Drummond","doi":"10.1080/19390211.2026.2719670","DOIUrl":"10.1080/19390211.2026.2719670","url":null,"abstract":"<p><p>Magnesium supplementation is commonly used to support sleep, but evidence remains mixed. This review evaluated randomized controlled trials of oral magnesium administered as a stand-alone intervention for sleep-related outcomes in adults. PubMed/MEDLINE, Scopus, Cochrane CENTRAL, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform were searched from inception to 1 June 2026. Eligible studies were randomized controlled trials evaluating magnesium as the only active intervention, or including a magnesium-only arm, and reporting at least one sleep-related outcome in adults. Trials involving nocturnal leg cramps, restless legs syndrome, or periodic limb movements were synthesized separately. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool, certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation approach, and findings were synthesized narratively because of study heterogeneity. Twelve randomized controlled trials were included in the main synthesis on sleep, insomnia, or poor sleep, and three additional trials involving movement- or cramp-related sleep disturbance were analyzed separately. One separately analyzed restless legs syndrome trial enrolled participants aged 15-50 years because adult-only data were unavailable. Populations, magnesium formulations, elemental doses, treatment durations, outcome roles, and measures varied substantially. Findings were inconsistent across subjective outcomes, EEG, research-grade actigraphy, consumer wearable-derived estimates, and physiological markers. Certainty of evidence was low to very low. Current evidence does not support oral magnesium as a routine treatment for insomnia. It may provide modest benefits for selected subjective outcomes in some adults, but the findings are inconsistent, and the certainty of the evidence is low or very low. Further well-designed, adequately powered trials are required before routine recommendations can be made.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"553-581"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148840548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ralf Jäger, Martin Purpura, Sebastian T Balcombe, Ashok Godavarthi, Suda A Reddy, Ecaterina Vasenina, Grant M Tinsley
{"title":"Effects of Tart Cherry Extract Supplementation on Plasma Urate and C-Reactive Protein Levels in Healthy Adults: a Randomized Controlled Trial.","authors":"Ralf Jäger, Martin Purpura, Sebastian T Balcombe, Ashok Godavarthi, Suda A Reddy, Ecaterina Vasenina, Grant M Tinsley","doi":"10.1080/19390211.2025.2589787","DOIUrl":"10.1080/19390211.2025.2589787","url":null,"abstract":"<p><p>Tart cherry (<i>Prunus cerasus</i> L.) extracts are plant extracts rich in polyphenolic compounds, particularly anthocyanins, which exhibit antioxidant and anti-inflammatory properties. These bioactives may help reduce plasma urate and C-reactive protein (CRP) levels, supporting cardiovascular and the management of hyperuricemia. Processing and formulation methods can influence tart cherry products stability and efficacy. To evaluate the effects of a standardized tart cherry extract on plasma urate and CRP levels. In a randomized, double-blind, placebo-controlled, crossover trial, 10 healthy subjects (n = 10; 6 male, 4 female, age: 34.9 ± 6.6 years, height: 155.3 ± 2.9 cm, weight: 67.1 ± 5.2 kg) consumed 500 mg of a European tart cherry (<i>Prunus cerasus</i> L.) extract powder or placebo for 4 wk, with a 14-day washout between treatment. Venous blood samples were collected at baseline and at 2-, 4-, and 8-h post-ingestion on day 1, as well as at 8 h post-ingestion on day 28, and were analyzed for plasma urate and CRP concentrations. Acute administration did not alter CRP or urate concentrations. Chronic supplementation significantly reduced CRP by 23.0% (- 1.36 ± 0.44 mg/L) and urate by 37.4% (-2.62 ± 0.44 mg/dL) compared to placebo (both p < 0.001). Four weeks of daily supplementation with 500 mg of tart cherry extract significantly reduced systemic inflammation and urate levels in healthy adults, supporting its potential as a polyphenol-rich, foodbased strategy for managing low-grade inflammation and hyperuricemia.</p>","PeriodicalId":15646,"journal":{"name":"Journal of Dietary Supplements","volume":" ","pages":"42-57"},"PeriodicalIF":2.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145540866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}